Rutgers New Jersey Medical School Selects Alpha Clinical Systems ACS360 eSource Platform for Clinical Trial Data Capture

PISCATAWAY, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Alpha Clinical Systems, the leading provider of affordable and comprehensive next-generation eSource solutions, today announced that Rutgers New Jersey Medical School has selected Alpha Clinical Systems’ cloud-based ACS360 eSource platform for clinical trial data capture.

Alpha Clinical Systems will provide the fully-integrated ACS360 platform, including Study Designer, ez-SourceDocx and Study Monitor, providing web-based study design, tablet-based direct eSource data capture and real-time, remote access to study data. The ACS360 platform is designed to help streamline study operations by providing truly paperless data capture and real-time access to validated study data, dramatically reducing study timelines and costs.

About Alpha Clinical Systems
Founded in 2009, Alpha Clinical Systems (ACS) is the leading provider of affordable and comprehensive next-generation eSource solutions. Developers of ACS360, a fully-integrated, cloud-based platform that provides direct eSource data capture with or without existing EDC systems. Working with small to mid-side sites, sponsors and CROs, Alpha Clinical Systems is dedicated to facilitating more widespread eSource adoption among life sciences companies. For more information visit us online at alphaclinicalsystems.com.

CONTACT: Media Contact: 
Alicia Maguire, Alpha Clinical Systems | 267.319.2093 | alicia@alphaclinicalsystems.com